Loading viewer...
earnings
Format: PDF earnings
Natera reported $820.2M in FY22 revenues with 37% growth and processed 2.07M tests. The company guides 2023 revenue of $980M-$1B while reducing cash burn by $150M, with significant expansion in oncology testing and multiple new clinical guideline endorsements for Signatera and carrier screening products.
earnings
21 Pages
earnings
20 Pages
Amedisys
Eastman Chemical 1Q 2023 Financial Results Earnings
earningsearnings
17 Pages
Eastman Chemical Company
TE Connectivity Q3 2016 Earnings Presentation
earningsearnings
33 Pages
TE Connectivity Limited